TRIVIUM-XXI, OOO, Moscow

Accounting reports

Previously

Name	TRIVIUM-XXI, OOO
INN	7705728698
KPP	771801001
OGRN	1067746538375
OKPO	95213201
Address	107564, G.MOSKVA, ul. Krasnobogatyrskaya, d. 38, pomesch. 11/3
Phone	+7 (495) 450-23-65

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities TRIVIUM-XXI, OOO according to EGRUL
46.46	Core activity	Wholesale of pharmaceutical goods
21.1	Additional activity	Pharmaceutical substances
21.10	Additional activity	Manufacture of manmade fibres
All types of activities
21.20	Additional activity	Manufacturers of drugs and pharmaceuticals and medical products
21.20.1	Additional activity	Production of drugs
21.20.2	Additional activity	Production of materials used in medical applications
46.46.1	Additional activity	Wholesale of furniture, carpets and lighting equipment
46.46.2	Additional activity	Wholesale of medical and orthopedic goods, dental and laboratory supplies

Registration information

Registration date	27.04.2006
Registering department	Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby N 46 po g. Moskve

Description

TRIVIUM-XXI, OOO (Moscow; INN 7705728698) was registered on 27 Apr 2006. The company's authorized capital as of July 1, 2012 was 526316 rub.

Type of ownership of TRIVIUM-XXI, OOO - Limited liability companies.

Form of ownership of TRIVIUM-XXI, OOO - Private property.

Principal activities of TRIVIUM-XXI, OOO: wholesale of pharmaceutical goods (46.46), pharmaceutical substances (21.1), manufacture of manmade fibres (21.10).

Industry

21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
- 21.1 - Pharmaceutical substances
  - 21.10 - Manufacture of manmade fibres
- 21.2 - The production of medicines and materials used in medical purposes
  - 21.20 - Manufacturers of drugs and pharmaceuticals and medical products
    - 21.20.1 - Production of drugs
    - 21.20.2 - Production of materials used in medical applications
46 - Wholesale trade (excluding motor vehicles)
- 46.4 - Wholesale of household goods
  - 46.46 - Wholesale of pharmaceutical goods
    - 46.46.1 - Wholesale of furniture, carpets and lighting equipment
    - 46.46.2 - Wholesale of medical and orthopedic goods, dental and laboratory supplies

Economic indicators

2023

Net profit (RAS) of TRIVIUM-XXI, OOO dropped in 2023 3.22 times to 18.93 million RUB from 60.94 million RUB over the same period in 2022, the company informed.

Revenue decreased in the accounting period by 48.05% to 311.92 million RUB from 600.46 million RUB in 2022.

2022

Net profit (RAS) of TRIVIUM-XXI, OOO grew over 2022 14.45 times to 60.94 million RUB from 4.22 million RUB over 2021, the company informed.

Revenue decreased in the accounting period by 7.62% to 600.46 million RUB from 649.96 million RUB in 2021.

2021

Net profit (RAS) of TRIVIUM-XXI, OOO dropped in 2021 6.81 times to 4.22 million RUB from 28.73 million RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period 2.21 times to 649.96 million RUB from 294.44 million RUB over 2020.

2020

Net profit (RAS) of TRIVIUM-XXI, OOO grew over 2020 by 23.92% to 28.73 million RUB from 23.18 million RUB over 2019, the company informed.

Revenue decreased in the accounting period by 1.18% to 294.44 million RUB from 297.95 million RUB in 2019.

2019

Net profit (RAS) of TRIVIUM-XXI, OOO dropped in 2019 2.86 times to 23.18 million RUB from 66.35 million RUB over the same period in 2018, the company informed.

Revenue decreased in the accounting period by 44.22% to 297.95 million RUB from 534.19 million RUB in 2018.

2013

Net profit (RAS) of TRIVIUM-XXI, OOO dropped in 2013 2.85 times to 13.32 million RUB from 37.98 million RUB over the same period in 2012, the company informed.

Revenue decreased in the accounting period by 38.51% to 103.20 million RUB from 167.84 million RUB in 2012; cost of goods sold decreased by 26.87% to 86.52 million RUB from 118.30 million RUB; sales profit fell 2.97 times to 16.68 million RUB from 49.54 million RUB.

2012

Net profit (RAS) of Trivium-XXI, OOO grew over 2012 2.42 times to 37.98 million RUB from 15.69 million RUB over 2011, the company informed.

Revenue decreased in the accounting period by 3.23% to 167.84 million RUB from 173.45 million RUB in 2011; cost of goods sold decreased by 22.05% to 118.30 million RUB from 151.77 million RUB.

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 388 616

Reports

17 430 571

Rrocessed requests

Extract from EGRUL:

Today, 7:35 PM

Accounting reports:

Today, 7:41 PM